U.S. market Closed. Opens in 1 day 9 hours 15 minutes

FBRX | Forte Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/A18.04M41.00K49.00K51.00K
Cost of Revenue9.00KN/A36.00K54.00K11.00KN/AN/AN/AN/A
Gross Profit-9.00KN/A-36.00K-54.00K-11.00K18.04M41.00K49.00K51.00K
Operating Expenses32.48M13.90M21.49M14.22M4.06M63.26M37.38M31.48M22.77M
Selling, General & Admin10.62M8.30M7.63M4.22M1.38M12.81M8.27M4.27M3.60M
Research & Development21.86M5.59M13.85M10.00M2.68M50.45M29.11M27.22M19.17M
Other Operating Expenses-1.0017.00K-222.00K-205.00K-6.85KN/AN/A-50.00KN/A
Operating Income-32.49M-13.90M-21.49M17.83M-4.06M-45.85M-37.63M-31.69M-22.95M
Other Expenses / Income1.01M17.00K-222.00K-205.00K-5.00K-1.40M-1.30M-1.79M-102.00K
Before Tax Income-31.48M-13.88M-21.71M-46.49M-4.07M-47.26M-38.93M-33.48M-23.06M
Income Tax ExpensesN/A-17.00K-200.56K32.06M-2.52K1.70M-2.60M-3.67M-204.00K
Net Income-31.48M-13.86M-21.71M-78.54M-4.07M-48.95M-38.93M-33.48M-23.06M
Interest ExpensesN/AN/AN/AN/AN/A173.38K1.93M-1.84M-102.00K
Basic Shares Outstanding1.26M695.34K558.71K294.36K84.33K53.49K38.95K52.74K48.63K
Diluted Shares Outstanding1.26M695.34K558.71K294.36K84.33K53.49K38.95K52.74K48.63K
EBITDA-32.48M-13.90M-21.45M-46.43M-4.05M-43.69M-36.70M-31.17M-22.48M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%-242.26%-89,524.39%-63,614.29%-44,088.24%
EBIT-31.48M-13.88M-21.91M-46.49M-4.07M-47.08M-39.60M-38.99M-23.36M
EBIT Margin0.00%0.00%0.00%0.00%0.00%-261.05%-96,578.05%-79,569.39%-45,807.84%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙